Ready to streamline your #assaydevelopment? Our NEW Assay Development Process Roadmap and Checklist offers: 🔵 A defined roadmap for the 3 phases of assay development 🔵 A summary of the goals and milestones of each stage 🔵 A simplified checklist of required activities Download it now: https://bit.ly/3xRDiUN
About us
Contract research and development organization offering development and testing services to the medical device, pharma, and consumer product industries. Area of expertise include biocompatibility, antimicrobial, novel coating, small molecule, peptide, and protein applications. iFyber offers unique expertise at the interface of chemistry, biotechnology and materials science. Our complementary skill sets help our customers efficiently advance their innovations and address untapped markets.
- Website
-
http://www.iFyber.com
External link for iFyber
- Industry
- Research Services
- Company size
- 11-50 employees
- Headquarters
- Ithaca, NY
- Type
- Privately Held
- Founded
- 2009
- Specialties
- Chemistry, Biotechnology, Materials Science, Contract Research, Spectroscopy, Virology, and Assay Development
Locations
-
Primary
Get directions
950 Danby Rd
Suite 198
Ithaca, NY 14850, US
Employees at iFyber
Updates
-
Avoid the cost of #preclinical research delays from studies that must be repeated due to incorrect testing. Discover insights to avoid these expensive mistakes from iFyber President, Greg Mouchka: https://bit.ly/3SrX8gR
-
-
The demand for more patient-centric, accessible, and efficient #healthcare is escalating. Mariely Medina-Rivera, a distinguished Research Scientist at iFyber, sheds light on the transformative journey from centralized clinical labs to POC and at-home testing: https://bit.ly/40wK3FB
-
-
Safeguard your medical products against viral threats with iFyber. Our expertise in #virology supports evaluating and mitigating risks for a diverse range of products, ensuring your devices are free of potential viruses and harmful pathogens. https://lnkd.in/g-kBaWJR
-
-
By gaining a deeper understanding of cytokine responses, we empower developers to fine-tune their products, ensuring they're optimized for maximum effectiveness before reaching clinical trials. Read the full white paper here: https://bit.ly/3nhuPEZ
-
-
While not all #microbial species are harmful, maintaining a balance is key to oral health. Dr. Fahimeh Tabatabaei, a dentist with a PhD in dental #biomaterials, explains how certain bacteria protect us, while others can cause disease when the balance is disrupted. Learn more: https://bit.ly/4de0zA4
-
-
With iFyber's carefully curated insights, you'll gain a deeper understanding of various assay options, enabling you to select the perfect one for your experiments. Stay ahead of the curve and maximize your research outcomes! https://ifyber.com/tools/
-
-
At its core, iFyber was founded on the principle of creatively solving problems at the interface between chemistry, biology, and materials science and our team reflects this mission. Learn more about Greg and meet the rest of our leadership team: https://lnkd.in/gTRf85jn
-